1De Jesus Araújo L, Braga Muniz G, Santos E, et al. (2013) Tuberous sclerosis complex diagnosed from oral lesions. Sao Paulo Med J. 131:351-355.

2Roach ES (2004) Miller VS. Neurocutaneous disorders. Cambridge University Press.

3De Jesus Araújo L, Yamamoto De Almeida L, Santos Lima J, MartelliJúnior H, et al. (2011) Evaluation of MMP-1, MMP-10, TIMP-1, a-SMA and TGF-b1 in angiofibromas of tuberous sclerosis. Minerva Stomatol 60:25-33.

4Araujo L de J, Lima LS, Alvarenga TM, et al. (2011) Oral and neurocutaneous phenotypes of familial tuberous sclerosis. Oral Surg Oral Med Oral Pathol Oral RadiolEndod 111:87-94.

5Stalker HJ, Zori RT (2005) Tuberous Sclerosis. R. C. Phillips Units Newsletter XVII (1).

6Osborne JP (1998) Diagnosis of tuberous sclerosis. Arch Dis Child 63:1423-1425.

7Mann L, Ebrahimi-Fakhari D, Heinrich B, et al. (2017) [ESPED- Survey: TSC-disease in children and adolescents: preliminary results from a German epidemiological survery]. Wien Med Wochenschr 167:271-275.

8Curatolo P, Bombardieri R, Jozwaik S (2008) Tuberous sclerosis. Lancet 372:657-68.

9Osborne JP, Fryer A, Webb D (1991) Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 615:125-127.

10Apak A, Haliloğlu G, Köse G, et al. (2003) Mutation analysis of the TSC2 gene in 33 Turkish familial cases with tuberous sclerosis. Turk J Pediatr 45:1-5.

11Rodrigues DA, Gomes CM, Costa IM (2012) Tuberous sclerosis complex. An Bras Dermatol87:184-196.

12Ebrahimi-Fakhari D, Meyer S, Vogt T, et al. (2017) Dermatological manifestations of tuberous sclerosis complex (TSC). J DtschDermatolGes 15:695-700.

13Northrup H, Krueger DA (2013) International Tuberous Sclerosis Complex Consensus G. Tuberous sclerosis complex diagnostic criteria update recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatric Neurol 49:243-254.

14Scully C (1997) Orofacial manifestations in tuberous sclerosis. Oral Surg Oral Med Oral Pathol 44:706-716.

15Sparling JD, Hong CH, Brahim JS, et al. (2007) Oral findings in 58 adults with tuberous sclerosis complex. J Am AcadDermatol 56:786-790.

16Mbibi SU, Segelnick SL, Weinberg MA (2015) Epithelia and Fibrous Hyperplasia: An oral Manifestation of Tuberous Sclerosis Complex. A Case Study. NY State Dent J 81:37- 41.

17Damm DD, Tomich CE, White DK (1999) Drummond JF. Intraosseous fibrous lesions of the jaws: a manifestation of tuberous sclerosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 87: 334-340.

18Scully C (1997) Orofacial manifestations in tuberous sclerosis. Oral Surg Oral Med Oral Pathol 44:706-716.

19Muzykewicz DA, Newberry P, Danforth N, et al. (2007) Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Epilepsy Behav11:506-513.

20Lopez-Lopez J, Rodriguez-de-Rivera-Campillo E, Marques-Soares MS, et al. (2004) Tuberous sclerosis and its oral manifestations. A clinical case. Med Oral 9:216-223.

21Devlin LA, Shepherd CH, Crawford H, Morrison PJ (2006) Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol 48:495-499.

22Flanagan N, O’Connor WJ, McCartan B, Miller S, et al. (1997) Developmental enamel defects in tuberous sclerosis: a clinical genetic marker? Jr Med Gene 34:637- 639.

23Asconape JJ (2002) Some common issues in the use of antiepileptic drugs. SeminNeurol 22:27-39.

24Samir H, Ghaffer HA, Nasr M (2011) Seizures and intellectual outcome: Clinico-radiological study of 30 Egyptian cases of tuberous sclerosis complex. Eur J Paediatr Neurol 15:131-137.